Membrane-disrupting peptide triggers immune response against cancer

Researchers developed a membranolytic peptide that ruptures tumor cell membranes, inducing immunogenic cell death. This process releases danger signals that activate the immune system against cancer, potentially enhancing existing immunotherapy approaches.

Sources (1)